Optimization of overall treatment time for whole gland stereotactic body radiotherapy with integrated focal boosting in prostate cancer KU Leuven
Prostate cancer (PCa) is the most frequently diagnosed cancer in males in Europe and is associated with substantial morbidity and mortality. In this project we aim to make progress in the disease management of PCa in terms of both treatment outcome (tumor control and toxicity outcome) and patient comfort including patients’ quality of life (QoL) during and after treatment. External beam radiotherapy (EBRT) is often used to treat primary PCa. ...